Platelet aggregation inhibitors in prevention and treatment of coronary thrombosis.
SourceNetherlands Journal of Medicine, 61, 6, (2003), pp. 185-92
Article / Letter to editor
Display more detailsDisplay less details
Netherlands Journal of Medicine
SubjectUMCN 2.1: Heart, lung and circulation
Platelet aggregation plays a key role in the development of complications of atherosclerosis. By inhibiting platelet aggregation in a pharmacological way complications such as myocardial infarction and sudden death may be prevented. This goes for primary as well as secondary prevention. The most relevant substances for this goal are aspirin, clopidogrel and the new glycoprotein IIb/IIIa inhibitors.
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.